<?xml version="1.0" encoding="UTF-8"?><rss version="2.0" xmlns:content="http://purl.org/rss/1.0/modules/content/"><channel><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><description>It takes nothing to join the crowd, but it takes everything to stand alone</description><managingEditor> (hellodword)</managingEditor><pubDate>Mon, 22 Mar 2021 07:19:36 +0800</pubDate><image><url>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</url><title>行舟Drug | wechat-feeds</title><link>http://MzUxNTM5MDcwMA.favicon.privacyhide.com/favicon.ico</link><width>64</width><height>64</height></image><item><title>严重副作用不同疾病的对应手册（面向患者·公众）（59）-头痛</title><link>https://mp.weixin.qq.com/s/reP8ZyQyllIGt-GiH3LKNg</link><description></description><content:encoded><![CDATA[严重副作用不同疾病的对应手册（面向患者·公众）（59）-头痛]]></content:encoded><pubDate>Sun, 21 Mar 2021 21:42:35 +0800</pubDate></item><item><title>​FDA 培训PPT：DMF有效沟通策略</title><link>https://mp.weixin.qq.com/s/nGkmJc_lj-pl5HFmNKV3oA</link><description></description><content:encoded><![CDATA[​FDA 培训PPT：DMF有效沟通策略]]></content:encoded><pubDate>Sun, 21 Mar 2021 21:42:35 +0800</pubDate></item><item><title>固体制剂生产工艺及验证要点（62页PPT）</title><link>https://mp.weixin.qq.com/s/K3OX8C9EktXYLsnZprDmLg</link><description></description><content:encoded><![CDATA[固体制剂生产工艺及验证要点（62页PPT）]]></content:encoded><pubDate>Sun, 21 Mar 2021 21:42:35 +0800</pubDate></item><item><title>CHO细胞表达重组单克隆抗体载体的构建策略</title><link>https://mp.weixin.qq.com/s/KLH_01g9PfSvRV8shhEpkg</link><description></description><content:encoded><![CDATA[CHO细胞表达重组单克隆抗体载体的构建策略]]></content:encoded><pubDate>Sun, 21 Mar 2021 21:42:35 +0800</pubDate></item><item><title>化疗无效后的生命奇迹：CAR-T免疫细胞疗法让我的淋巴瘤彻底消失了</title><link>https://mp.weixin.qq.com/s/aZaJrMhO6Hdxy1cav8vzKw</link><description></description><content:encoded><![CDATA[化疗无效后的生命奇迹：CAR-T免疫细胞疗法让我的淋巴瘤彻底消失了]]></content:encoded><pubDate>Sat, 20 Mar 2021 19:05:41 +0800</pubDate></item><item><title>临床期间药学变更报不报？你说了算！</title><link>https://mp.weixin.qq.com/s/QcMaVDR8A_LFzfhEgyJteA</link><description></description><content:encoded><![CDATA[临床期间药学变更报不报？你说了算！]]></content:encoded><pubDate>Sat, 20 Mar 2021 19:05:41 +0800</pubDate></item><item><title>全球ADC简要梳理</title><link>https://mp.weixin.qq.com/s/3KneeapDXGvvkqYpZbB-2A</link><description></description><content:encoded><![CDATA[全球ADC简要梳理]]></content:encoded><pubDate>Sat, 20 Mar 2021 19:05:41 +0800</pubDate></item><item><title>【干货收藏】药用辅料功能性指标对BE的影响——黄原胶 &amp; 枸橼酸（篇）</title><link>https://mp.weixin.qq.com/s/pCNgK2c3OozjwnjrfQnIkw</link><description></description><content:encoded><![CDATA[【干货收藏】药用辅料功能性指标对BE的影响——黄原胶 & 枸橼酸（篇）]]></content:encoded><pubDate>Fri, 19 Mar 2021 21:12:41 +0800</pubDate></item><item><title>浅谈欧洲药品专利期补偿制度的现状和发展趋势</title><link>https://mp.weixin.qq.com/s/H3-ibU3d0U9-oBaoKYh_kA</link><description></description><content:encoded><![CDATA[浅谈欧洲药品专利期补偿制度的现状和发展趋势]]></content:encoded><pubDate>Fri, 19 Mar 2021 21:12:41 +0800</pubDate></item><item><title>制剂设备工作原理图</title><link>https://mp.weixin.qq.com/s/uuvkQRRWLkR0quVwZfF4AQ</link><description></description><content:encoded><![CDATA[制剂设备工作原理图]]></content:encoded><pubDate>Fri, 19 Mar 2021 21:12:41 +0800</pubDate></item><item><title>同行分享|CAR-T生产工艺及临床应用指南</title><link>https://mp.weixin.qq.com/s/h_E4fqyLXz7zKc5P8-pP2Q</link><description></description><content:encoded><![CDATA[同行分享|CAR-T生产工艺及临床应用指南]]></content:encoded><pubDate>Fri, 19 Mar 2021 21:12:41 +0800</pubDate></item><item><title>浅析——药品上市后变更程序及创新药临床期间变更程序</title><link>https://mp.weixin.qq.com/s/U7xzxGqAaCy9ALQXAbxi_w</link><description></description><content:encoded><![CDATA[浅析——药品上市后变更程序及创新药临床期间变更程序]]></content:encoded><pubDate>Thu, 18 Mar 2021 19:40:14 +0800</pubDate></item><item><title>《医疗器械监督管理条例》全文发布！</title><link>https://mp.weixin.qq.com/s/Bjb0vthP7PXZSc3aqgxF9g</link><description></description><content:encoded><![CDATA[《医疗器械监督管理条例》全文发布！]]></content:encoded><pubDate>Thu, 18 Mar 2021 19:40:14 +0800</pubDate></item><item><title>干货 | 药品研发中的原辅料相容性实验</title><link>https://mp.weixin.qq.com/s/_Td0XGslAu1pHg4BxPUWYQ</link><description></description><content:encoded><![CDATA[干货 | 药品研发中的原辅料相容性实验]]></content:encoded><pubDate>Thu, 18 Mar 2021 19:40:14 +0800</pubDate></item><item><title>《药品注册管理办法》48个热点问题答疑</title><link>https://mp.weixin.qq.com/s/0oSvm-1umE8cTyzFWgcKVA</link><description></description><content:encoded><![CDATA[《药品注册管理办法》48个热点问题答疑]]></content:encoded><pubDate>Wed, 17 Mar 2021 20:56:05 +0800</pubDate></item><item><title>最新！肝癌防治策略：《原发性肝癌二级预防共识（2021年版）》（全文）</title><link>https://mp.weixin.qq.com/s/StF5sHJmhswk675-kiomkw</link><description></description><content:encoded><![CDATA[最新！肝癌防治策略：《原发性肝癌二级预防共识（2021年版）》（全文）]]></content:encoded><pubDate>Wed, 17 Mar 2021 20:56:05 +0800</pubDate></item><item><title>2020版药典变更解读（94页PPT）</title><link>https://mp.weixin.qq.com/s/Aydw17CX9_f_2HQKkMKahg</link><description></description><content:encoded><![CDATA[2020版药典变更解读（94页PPT）]]></content:encoded><pubDate>Tue, 16 Mar 2021 20:29:16 +0800</pubDate></item><item><title>CDE快讯《皮肤外用化学仿制药研究技术指导原则（试行）》</title><link>https://mp.weixin.qq.com/s/Tr-p7SSvMrnGVF67NuX52g</link><description></description><content:encoded><![CDATA[CDE快讯《皮肤外用化学仿制药研究技术指导原则（试行）》]]></content:encoded><pubDate>Tue, 16 Mar 2021 20:29:16 +0800</pubDate></item><item><title>卫健委刚刚发布《涉及人的生命科学和医学研究伦理审查办法（征求意见稿）》</title><link>https://mp.weixin.qq.com/s/CJG4dw_wDywriQJMvl_LpA</link><description></description><content:encoded><![CDATA[卫健委刚刚发布《涉及人的生命科学和医学研究伦理审查办法（征求意见稿）》]]></content:encoded><pubDate>Tue, 16 Mar 2021 20:29:16 +0800</pubDate></item><item><title>CAR-T细胞生产中的问题和挑战</title><link>https://mp.weixin.qq.com/s/r-6nxYNZAB4RNVA9fu-p9A</link><description></description><content:encoded><![CDATA[CAR-T细胞生产中的问题和挑战]]></content:encoded><pubDate>Tue, 16 Mar 2021 20:29:16 +0800</pubDate></item></channel></rss>